in ,

Army Picks Battelle to Develop Vaccines for Biological, Chemical Threats Under $59M Contract

Army Picks Battelle to Develop Vaccines for Biological, Chemical Threats Under $59M Contract - top government contractors - best government contracting event
https://executivebiz-media.s3.amazonaws.com/2022/08/19/30/9f/c3/a0/b7/6f/d4/64/Executive-Biz.png

Health research managementBattelle has received a potential five-year, $59 million contract from the U.S. Army to conduct research and develop therapeutics and vaccines for chemical and biological threats.

The Army“™s joint program executive office for chemical and biological defense awarded the contract through the General Services Administration“˜s One Acquisition Solution for Integrated Services contract vehicle, Battelle said Monday.

Battelle will work to develop vaccines for filovirus, botulinum, plague, equine encephalitis and other viruses that could be potentially used as biological weapons.

Contract work also covers the development of medical countermeasures against poisonous toxins and nerve agents used in chemical warfare.

ExecutiveBiz Logo

Sign Up Now! ExecutiveBiz provides you with Daily Updates and News Briefings about Products & Service

mm

Written by Jane Edwards

is a staff writer at Executive Mosaic, where she writes for ExecutiveBiz about IT modernization, cybersecurity, space procurement and industry leaders’ perspectives on government technology trends.

DISA to Solicit Proposals for DoD milCloud 2 Phase 1 Contract by June 6 - top government contractors - best government contracting event
DISA to Solicit Proposals for DoD milCloud 2 Phase 1 Contract by June 6
F-35 Joint Program Office Issues RFI on Knowledge-Based IT Services - top government contractors - best government contracting event
F-35 Joint Program Office Issues RFI on Knowledge-Based IT Services